These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 20869438)
1. PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors. Parajó Y; d'Angelo I; Horváth A; Vantus T; György K; Welle A; Garcia-Fuentes M; Alonso MJ Eur J Pharm Sci; 2010 Dec; 41(5):644-9. PubMed ID: 20869438 [TBL] [Abstract][Full Text] [Related]
2. Improved delivery of angiogenesis inhibitors from PLGA:poloxamer blend micro- and nanoparticles. d'Angelo I; Parajó Y; Horváth A; Kéri G; La Rotonda MI; Alonso MJ J Microencapsul; 2010; 27(1):57-66. PubMed ID: 19545221 [TBL] [Abstract][Full Text] [Related]
3. Nanoparticles based on PLGA:poloxamer blends for the delivery of proangiogenic growth factors. d'Angelo I; Garcia-Fuentes M; Parajó Y; Welle A; Vántus T; Horváth A; Bökönyi G; Kéri G; Alonso MJ Mol Pharm; 2010 Oct; 7(5):1724-33. PubMed ID: 20681555 [TBL] [Abstract][Full Text] [Related]
4. PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: new carriers for gene delivery. Csaba N; Caamaño P; Sánchez A; Domínguez F; Alonso MJ Biomacromolecules; 2005; 6(1):271-8. PubMed ID: 15638530 [TBL] [Abstract][Full Text] [Related]
5. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091 [TBL] [Abstract][Full Text] [Related]
6. PLGA-based drug delivery systems: importance of the type of drug and device geometry. Klose D; Siepmann F; Elkharraz K; Siepmann J Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140 [TBL] [Abstract][Full Text] [Related]
7. Design and optimization of NSAID loaded nanoparticles. Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573 [TBL] [Abstract][Full Text] [Related]
8. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance. Liu Y; Pan J; Feng SS Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049 [TBL] [Abstract][Full Text] [Related]
9. Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model. Formiga FR; Pelacho B; Garbayo E; Abizanda G; Gavira JJ; Simon-Yarza T; Mazo M; Tamayo E; Jauquicoa C; Ortiz-de-Solorzano C; Prósper F; Blanco-Prieto MJ J Control Release; 2010 Oct; 147(1):30-7. PubMed ID: 20643169 [TBL] [Abstract][Full Text] [Related]
10. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles. Niu X; Zou W; Liu C; Zhang N; Fu C Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638 [TBL] [Abstract][Full Text] [Related]
11. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265 [TBL] [Abstract][Full Text] [Related]
12. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles. Kumar PS; Ramakrishna S; Saini TR; Diwan PV Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069 [TBL] [Abstract][Full Text] [Related]
14. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Kim DH; Martin DC Biomaterials; 2006 May; 27(15):3031-7. PubMed ID: 16443270 [TBL] [Abstract][Full Text] [Related]
15. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil. Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221 [TBL] [Abstract][Full Text] [Related]
16. Design of polymeric nanoparticles and its applications as drug delivery systems for acne treatment. Reis CP; Martinho N; Rosado C; Fernandes AS; Roberto A Drug Dev Ind Pharm; 2014 Mar; 40(3):409-17. PubMed ID: 23480566 [TBL] [Abstract][Full Text] [Related]
17. A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors. Chung YI; Tae G; Hong Yuk S Biomaterials; 2006 Apr; 27(12):2621-6. PubMed ID: 16360204 [TBL] [Abstract][Full Text] [Related]
18. Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique. Paillard-Giteau A; Tran VT; Thomas O; Garric X; Coudane J; Marchal S; Chourpa I; Benoît JP; Montero-Menei CN; Venier-Julienne MC Eur J Pharm Biopharm; 2010 Jun; 75(2):128-36. PubMed ID: 20226857 [TBL] [Abstract][Full Text] [Related]
19. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. Budhian A; Siegel SJ; Winey KI Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944 [TBL] [Abstract][Full Text] [Related]
20. Improved bioavailability of orally administered mifepristone from PLGA nanoparticles. He W; Horn SW; Hussain MD Int J Pharm; 2007 Apr; 334(1-2):173-8. PubMed ID: 17101249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]